Effect of enoxaparin on the safety, tolerability, pharmacodynamics and pharmacokinetics of BAY 59–7939 – an oral, direct Factor Xa inhibitor. J Thromb Haemost - Kubitza, D; Becka, M; Voith, B (2005)
(Suppl 1): Abstract P1704.